Sethu Sankaranarayanan

Sethu Sankaranarayanan has extensive work experience in the biotechnology and pharmaceutical industry. Sethu is currently the VP Preclinical and Translational Sciences at Nine Square Therapeutics, a role they took on in October 2022. Prior to that, they served as the VP Translational Biomarkers at ESCAPE Bio from an unspecified start date in 2021 until an unspecified end date in 2022. Sethu also worked at Annexon Biosciences, where they held the positions of Senior Director from 2017 to 2021 and Director from 2015 to 2017. Before joining Annexon Biosciences, they worked at Bristol-Myers Squibb as a Senior Principal Scientist from 2007 to 2015. Sethu began their career at Merck Research Labs as a Research Fellow in 2002 and stayed in that position until 2007.

Sethu Sankaranarayanan has pursued higher education in the field of neuroscience and physiology. It is known that they attended Washington State University to obtain a PhD in Neuroscience. The specific start and end years are not provided. Additionally, Sethu also enrolled in the Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo, focusing on Physiology. The duration of this program is unspecified as well.